期刊文献+
共找到260篇文章
< 1 2 13 >
每页显示 20 50 100
Endoscopic Management of Severe Supraglottic and Posterior Glottic Stenosis Due to Chemotherapy and Radiation
1
作者 Shaina M. Rubino Michael J. Pitman 《International Journal of Otolaryngology and Head & Neck Surgery》 2014年第3期133-136,共4页
Combined posterior and supraglottic stenosis (CS) often presents as debilitating dysphonia or dyspnea, secondary to blunt trauma or traumatic intubation. However, CS has proven to be a late complication of chemoradiat... Combined posterior and supraglottic stenosis (CS) often presents as debilitating dysphonia or dyspnea, secondary to blunt trauma or traumatic intubation. However, CS has proven to be a late complication of chemoradiation therapy. Traditional treatment of combined posterior and supraglottic stenosis (CS) secondary to chemoradiation has been frequently complicated by poor tissue healing. This case study illustrates a novel endoscopic surgical technique employing a large laterally-based flap as a posterior glottic keel by rotating it anteroinferiorly and suturing it in place. As a result of the procedure, the bilateral vocal folds, which were midline and immobile preoperatively, regained normal motion. The supraglottic airway was also restored. Successful endoscopic treatment of CS with bilateral vocal fold immobility is possible using a large laterally-based flap, even in the face of tissue changes secondary to chemoradiation. 展开更多
关键词 POSTERIOR glottic STENOSIS SUPRAglottic STENOSIS Combined glottic STENOSIS RADIATION Endoscopic Surgery
下载PDF
Clinical Outcome of Definitive Radiotherapy and/or Surgery in T1-2N0M0 Glottic Squamous Cell Carcinoma: A Single Institution Retrospective Report
2
作者 Dina Ragab Diab Ibrahim Anas Mohamed Askoura Mohammed Aleem 《Journal of Cancer Therapy》 2018年第2期163-178,共16页
Background: The current treatment options of early glottic carcinoma are radiotherapy;trans laser microsurgery, and open surgery. However, the best treatment is still controversial due to lack of randomized controlled... Background: The current treatment options of early glottic carcinoma are radiotherapy;trans laser microsurgery, and open surgery. However, the best treatment is still controversial due to lack of randomized controlled trials. We aimed to evaluate the treatment results and the prognostic factors of local control of early glottic squamous cell carcinoma patients (GSCC) T1-2N0M0 treated at our institution. Material and Methods: We retrospectively studied the charts of 52 patients with early GSCC T1-T2N0M0 from 2010-2015 at the Clinical Oncology Department, Ain-Shams University. 24 patients had T1 and 28 had T2 early glottic carcinoma. The overall survival OS, local control rate, and laryngeal preservation rate were evaluated. Kaplan-Meier method, Cox proportional hazards model were used to analyze the data. Results: Median duration of follow-up was 13 months. Thirty-eight patients received radiation treatment alone (73.1%), 7.7% of the patients underwent surgery alone, and 19.2% of the patients had surgery combined with radiotherapy. Local recurrence after radiation failure developed in 6/52 patients, all had T2 disease and were salvaged by total laryngectomy. The ultimate local control rate was 88.5%, and the ultimate laryngeal preservation rate was 77.2% (40/52 patients). The median OS of the 52 patients was 13 months (range 2 - 46 months). Univariate analysis of factors associated with poor local control showed that age > 60 years was the only significant factor (P = 0.048). Conclusion: Radiotherapy achieves high local control and laryngeal preservation rates for patients with early glottic carcinoma, and is associated with a low rate of severe complications compared to surgery. Salvage surgery is feasible after radiotherapy failure. 展开更多
关键词 LARYNX glottic SQUAMOUS Cell Carcinoma Outcome Radiotherapy SURGERY
下载PDF
Radiotherapy and Chemotherapy in T2N0 Glottic Cancer: Does Chemotherapy Improve Local Control?
3
作者 Takashi Kosugi Kazunori Suzuki +2 位作者 Kenta Konishi Hotaka Nonaka Hiroyuki Mineta 《Journal of Cancer Therapy》 2013年第2期513-517,共5页
Purpose: To compare concurrent chemoradiotherapy with radiotherapy in T2N0 glottic cancer. Materials and Methods: Thirty nine patients were treated with radiotherapy alone. In detail, 30 patients treated between 1985 ... Purpose: To compare concurrent chemoradiotherapy with radiotherapy in T2N0 glottic cancer. Materials and Methods: Thirty nine patients were treated with radiotherapy alone. In detail, 30 patients treated between 1985 and 1995, and 9 patients treated between 1995 and 2010 were included in the radiotherapy alone group. Between 1995 and 2010, 22 patients were treated with concurrent chemoradiotherapy. Conventional fractionation was applied in 19 patients in the radiotherapy group and in 1 patient in the chemoradiotherapy group. Hyperfractionation was applied to 20 patients in the radiotherapy group and to 21 patients in the chemoradiotherapy group. Total dose ranged from 64 Gy to 76.8 Gy in the radiotherapy group and from 66 Gy to 76.8 Gy in the chemoradiotherapy group. Cisplatin or carboplatin was administered in the chemoradiotherapy group. Results: There were no differences in the 5-year preservation rate of vocal function (82.8% vs 87.4%, p = 0.652), local control rate (77.2% vs 92.9%, p = 0.163), and 5-year overall survival rate (86.4% vs 90.2%, p = 0.497) between the radiotherapy and chemoradiotherapy groups. Conclusion: In T2N0 glottic cancer, no difference was observed between radiotherapy alone and concurrent chemoradiotherapy groups. 展开更多
关键词 T2 glottic Cancer Radiation Therapy CHEMOTHERAPY VOICE PRESERVATION Local Control
下载PDF
An Analysis of the Global and Partial Voice Handicap Index in Patients with Early Glottic Carcinoma Treated with High Level of Irradiation
4
作者 Daniela Musio Francesca De Felice +6 位作者 Cristina Bigelli Nadia Bulzonetti Roberta Guarnaccia Mario Tombolini Giovanni Ruoppolo Marco de Vincentiis Vincenzo Tombolini 《Journal of Cancer Therapy》 2014年第1期21-27,共7页
Background: This is a retrospective study on a group of patients with early glottic carcinoma, treated with curative radiotherapy. The aim of the study is to assess voice quality after treatment. We also evaluated loc... Background: This is a retrospective study on a group of patients with early glottic carcinoma, treated with curative radiotherapy. The aim of the study is to assess voice quality after treatment. We also evaluated local recurrence, overall survival, disease free survival and toxicity. Material and Methods: We examined a total of 36 patients, out of which 27 were smokers: 10 females/5 smokers;26 males/22 smokers. The sample was observed from January 2007 to July 2012 (average follow-up period: 33.5 months, range 12 - 76). Diagnosis of early glottic carcinoma was eight during the two-year period 2007/2008, nine during 2009/2010, eleven during year 2011 and eight during year 2012. All patients suffering from early glottic carcinoma, histopathologically confirmed, were classified as follows: 24 patients T1a, 3 patients T1b, 6 patients T2 and 3 patients had a carcinoma in situ. They were treated only with conventional radiotherapy. After the treatment (total dose 70 Gy), patients were asked to fill out the Voice Handicap Index (VHI) questionnaire, composed of 30 questions that covered physical, emotional and functional areas. Results: The global VHI was evidenced with good voice quality (62% of patients: VHI < 30;34% of patients: VHI 31 - 60). Vocal disability was mild in over 70% of patients within the physical area and over 80% within the emotional area. We observed two local recurrences, one occurred five years after the end of radiation therapy and one six months after. In terms of toxicity, we observed that acute reactions, such as dysphonia, dysphagia and erythema, were relatively limited. Conclusions: The VHI index suggests that radiotherapy produces acceptable functional results, with limited repercussion on life quality. In line with literature, our data confirmed good cure rates and larynx preservation (94.4%). 展开更多
关键词 glottic Carcinoma VOICE HANDICAP Index RADIOTHERAPY
下载PDF
A Combination of Endoscopic CO<sub>2</sub>Laser Microsurgery and Radiotherapy for Treatment of T2N0M0 Glottic Carcinoma
5
作者 Motohiro Sawatsubashi Toshiro Umezaki +1 位作者 Takemoto Shin Shizuo Komune 《International Journal of Otolaryngology and Head & Neck Surgery》 2012年第2期28-33,共6页
The aims of this study were to evaluate the results of CO2 laser surgery alone and CO2 laser surgery combined with radiotherapy in patients with T2N0M0 glottic carcinoma. A retrospective analysis was conducted of 35 c... The aims of this study were to evaluate the results of CO2 laser surgery alone and CO2 laser surgery combined with radiotherapy in patients with T2N0M0 glottic carcinoma. A retrospective analysis was conducted of 35 cases of T2N0M0 glottic carcinoma. Fourteen patients with normal vocal cord mobility were treated with endoscopic CO2 laser surgery alone. The remaining 21 patients were treated with CO2 laser surgery followed by radiotherapy (44 - 70 Gy, including low-dose carboplatin chemoradiotherapy). Main outcome measures were local control, organ preservation, recurrence, 5-year survival, and successful salvage in cases of recurrence. We evaluated the patient’s voice with the psychoacoustics GRBAS scale, maximum phonation time (MPT), and airflow rate (AFR) obtained by aerodynamic tests. Mean follow-up period was 5 years. Among the 35 T2N0M0 patients, 5-year survival and 5-year voice preservation rates were 97% and 89%, respectively. Local recurrence occurred in 7 of these patients (20%);4 of 7 local recurrences were successfully re-treated by laser surgery. Total laryngectomy was necessary for salvage treatment in the remaining 3 patients. The post-treatment voice qualities were judged to be the same or improved over pretreatment qualities. There was little change in MPT and AFR after treatment in non-recurrence patients. CO2 laser microsurgery is an excellent tool for treating selected cases of T2N0M0 展开更多
关键词 T2 glottic Carcinoma Laryngeal Cancer ENDOSCOPIC LASER Surgery CHEMORADIOTHERAPY
下载PDF
A self-fused hydrogel for the treatment of glottic insufficiency through outstanding durability,extracellular matrix-inducing bioactivity and function preservation
6
作者 Chen-Yu Zou Juan-Juan Hu +8 位作者 Dan Lu Qian-Jin Li Yan-Lin Jiang Rui Wang Hai-Yang Wang Xiong-Xin Lei Jesse Li-Ling Hui Yang Hui-Qi Xie 《Bioactive Materials》 SCIE CSCD 2023年第6期54-68,共15页
Injection laryngoplasty with biomaterials is an effective technique to treat glottic insufficiency.However,the inadequate durability,deficient pro-secretion of extracellular matrix(ECM)and poor functional preservation... Injection laryngoplasty with biomaterials is an effective technique to treat glottic insufficiency.However,the inadequate durability,deficient pro-secretion of extracellular matrix(ECM)and poor functional preservation of current biomaterials have yielded an unsatisfactory therapeutic effect.Herein,a self-fusing bioactive hydrogel comprising modified carboxymethyl chitosan and sodium alginate is developed through a dual-crosslinking mechanism(photo-triggered and dynamic covalent bonds).Owing to its characteristic networks,the synergistic effect of the hydrogel for vocal folds(VFs)vibration and phonation is adequately demonstrated.Notably,owing to its inherent bioactivity of polysaccharides,the hydrogel could significantly enhance the secretion of major components(type I/III collagen and elastin)in the lamina propria of the VFs both in vivo and in vitro.In a rabbit model for glottic insufficiency,the optimized hydrogel(C1A1)has demonstrated a durability far superior to that of the commercially made hyaluronic acid(HA)Gel.More importantly,owing to the ECM-inducing bioactivity,the physiological functions of the VFs treated with the C1A1 hydrogel also outperformed that of the HA Gel,and were similar to those of the normal VFs.Taken together,through a simple-yet-effective strategy,the novel hydrogel has demonstrated outstanding durability,ECM-inducing bioactivity and physiological function preservation,therefore has an appealing clinical value for treating glottic insufficiency. 展开更多
关键词 glottic insufficiency Self-fusion HYDROGEL Extracellular matrix Physiological function
原文传递
Lemierre综合征患者机械通气撤机后继发声门闭合不全的护理
7
作者 周飞飞 高春华 林燕 《中华急危重症护理杂志》 CSCD 2024年第1期47-50,共4页
总结1例Lemierre综合征患者机械通气撤机后继发声门闭合不全的护理体会。针对患者撤机难度大,再插管风险高等问题,采取急性期呼吸支持;拔管前风险评估、多学科制订拔管策略、拔管后观察与应急处置;预警评估,平衡出血与血栓,积极控制感染... 总结1例Lemierre综合征患者机械通气撤机后继发声门闭合不全的护理体会。针对患者撤机难度大,再插管风险高等问题,采取急性期呼吸支持;拔管前风险评估、多学科制订拔管策略、拔管后观察与应急处置;预警评估,平衡出血与血栓,积极控制感染,预防交叉感染;阶段性康复训练,目标导向营养支持及正性心理支持等措施。经过25 d积极治疗与护理,患者病情好转,转康复医院继续治疗。随访3个月,患者生活恢复正常。 展开更多
关键词 Lemierre综合征 声门闭合不全 通气机撤除法 危重病护理
下载PDF
T_(1b)声门型喉癌的治疗现状
8
作者 刘鑫 吕元景 项丞 《现代肿瘤医学》 CAS 2024年第4期774-777,共4页
声门型喉癌治疗方式的选择决定着患者的生存质量和预后,T_(1b)声门型喉癌有多种治疗方式,各方式有不同的优势与不足,本文综述T_(1b)声门型喉癌的治疗现状。
关键词 T_(1b)声门型喉癌 经口激光显微手术 放射治疗 开放性部分喉切除术 低温等离子射频消融
下载PDF
等离子射频消融术与CO_(2)激光治疗早期声门型喉癌的效果比较
9
作者 洪伟 刘慧娟 苏武 《癌症进展》 2024年第4期385-388,共4页
目的比较等离子射频消融术与CO_(2)激光治疗早期声门型喉癌(EGC)的效果。方法根据治疗方法的不同将80例EGC患者分为对照组(n=40,CO_(2)激光)与研究组(n=40,等离子射频消融术),比较两组患者的围手术期指标[手术时间、术中出血量、术后住... 目的比较等离子射频消融术与CO_(2)激光治疗早期声门型喉癌(EGC)的效果。方法根据治疗方法的不同将80例EGC患者分为对照组(n=40,CO_(2)激光)与研究组(n=40,等离子射频消融术),比较两组患者的围手术期指标[手术时间、术中出血量、术后住院时间、术后24 h视觉模拟评分法(VAS)评分]、嗓音功能[振幅微扰、谐噪比(HNR)、基频微扰]、生活质量[嗓音障碍指数(VHI)]、吞咽功能[电视透视吞咽功能检查(VFSS)]、局部复发情况及并发症发生情况。结果研究组患者手术时间、术后住院时间均明显短于对照组,术中出血量明显少于对照组,术后24 h VAS评分明显低于照组,差异均有统计学意义(P﹤0.01)。术后4周,两组患者HNR均高于本组术前,基频微扰、振幅微扰均低于本组术前,研究组患者HNR高于对照组,基频微扰、振幅微扰均低于对照组,差异均有统计学意义(P﹤0.05)。术后6个月,两组患者VHI评分均低于本组术前,VFSS评分均高于本组术前,研究组患者VHI评分低于对照组,VFSS评分高于对照组,差异均有统计学意义(P﹤0.05)。研究患者的局部复发率和并发症总发生率均低于对照组,但差异均无统计学意义(P﹥0.05)。结论与CO_(2)激光相比,等离子射频消融术治疗EGC的效果更好,可以缩短手术时间,减少术中出血量,减轻术后疼痛感,同时对患者嗓音、吞咽功能的影响较小,可以促进患者术后快速康复,并且提高生活质量。 展开更多
关键词 早期声门型喉癌 CO_(2)激光 等离子射频消融术 治疗效果
下载PDF
早期声门型喉癌患者放疗的临床疗效观察与预后影响因素分析 被引量:2
10
作者 刘沛 翟红丽 程呈 《实用癌症杂志》 2023年第3期437-439,共3页
目的 分析早期声门型喉癌患者放疗的临床疗效与预后影响因素。方法 选取早期声门型喉癌患者102例,均行常规放疗,统计疗效、复发率,采用自制调查问卷收集患者性别、年龄、分化程度、临床分期、淋巴结转移信息,分析预后影响因素。结果 放... 目的 分析早期声门型喉癌患者放疗的临床疗效与预后影响因素。方法 选取早期声门型喉癌患者102例,均行常规放疗,统计疗效、复发率,采用自制调查问卷收集患者性别、年龄、分化程度、临床分期、淋巴结转移信息,分析预后影响因素。结果 放疗总有效率为88.24%(90/102),复发率为17.65%(18/102)。性别、年龄、临床分期、淋巴结转移是影响声门型喉癌患者预后的单因素(P<0.05);logistic回归分析显示,男性、≥60岁、Ⅱ期、存在淋巴结转移是声门型喉癌预后的危险因素(P<0.05)。结论 早期声门型喉癌患者应用放疗治疗效果确切,但仍存在复发风险,且老年、男性、临床分期Ⅱ期、淋巴结转移是声门型喉癌患者预后危险因素,临床可据此实施防控措施。 展开更多
关键词 早期声门型喉癌 放疗 临床疗效 预后影响因素
下载PDF
不同术式治疗T1a期声门型喉癌的嗓音功能评估
11
作者 王燕 屈季宁 +3 位作者 周涛 华清泉 雷薇薇 舒婧 《听力学及言语疾病杂志》 CAS CSCD 北大核心 2023年第6期509-513,共5页
目的对比CO_(2)激光、低温等离子刀切除术两种术式治疗早期声门型喉癌的嗓音恢复情况。方法回顾性分析2017年1月~2019年12月在武汉大学人民医院进行CO_(2)激光和等离子刀切除术治疗的42例T1aN0M0期声门型喉癌患者的临床资料,分为两组,A... 目的对比CO_(2)激光、低温等离子刀切除术两种术式治疗早期声门型喉癌的嗓音恢复情况。方法回顾性分析2017年1月~2019年12月在武汉大学人民医院进行CO_(2)激光和等离子刀切除术治疗的42例T1aN0M0期声门型喉癌患者的临床资料,分为两组,A组20例,采用低温等离子刀切除术治疗;B组22例,采用CO_(2)激光切除术治疗。根据病变范围,按内镜下声带切除术分类标准指南,40例患者采用Ⅲ型手术,2例采用Ⅳ型手术。术中取切缘进行冰冻病理检查,阴性即可结束手术。手术前及术后3、6、9及12个月应用嗓音障碍指数VHI-10、听感知评估GRABS及多维嗓音分析软件对患者嗓音功能进行评估,动态喉镜检查观察声带形态及黏膜波,比较两组结果。结果①两组患者术后3个月时,jitter、shimmer及NHR数值明显增高,随着时间推移,jitter、shimmer及NHR数值逐渐降低,到9个月以后,以上观察指标趋于稳定。②术后9个月时,B组嗓音功能恢复优于A组。主观听感知方面,B组术后嗓音障碍程度轻于A组;两组间jitter值差异有统计学意义(P<0.05)。③动态喉镜检查:B组术后声带闭合、运动的对称性、黏膜波、振动规律性优于A组(P<0.05)。结论对T1a期声门型喉癌患者,CO_(2)激光术后患者嗓音功能恢复情况优于低温等离子射频手术。 展开更多
关键词 声门型喉癌 CO_(2)激光 等离子刀 嗓音功能
下载PDF
低温等离子射频消融术与喉部分切除术治疗早期声门型喉癌的效果及对喉功能恢复的影响 被引量:1
12
作者 易春曦 吴亚男 《临床医学研究与实践》 2023年第22期97-100,共4页
目的比较低温等离子射频消融术与喉部分切除术治疗早期声门型喉癌的效果。方法选择2019年1月至2020年12月我院收治的100例早期声门型喉癌患者为研究对象,以治疗方案不同将其分为常规组(50例,喉部分切除术)和观察组(50例,低温等离子射频... 目的比较低温等离子射频消融术与喉部分切除术治疗早期声门型喉癌的效果。方法选择2019年1月至2020年12月我院收治的100例早期声门型喉癌患者为研究对象,以治疗方案不同将其分为常规组(50例,喉部分切除术)和观察组(50例,低温等离子射频消融术)。比较两组的治疗效果。结果观察组的手术时长、住院时长、手术部位黏膜恢复时间短于常规组,术中出血量少于常规组,术后1、3 d的视觉模拟量表(VAS)评分低于常规组(P<0.05)。观察组的切口感染、刺激性咳嗽、喉狭窄、咯血、声带粘连发生率及1年内复发率低于常规组(P<0.05)。术后1、3个月,观察组的基频微扰、振幅微扰低于常规组,谐噪比、吞咽功能及简明健康状况调查表(SF-36)评分高于常规组(P<0.05)。结论低温等离子射频消融术较喉部分切除术治疗早期声门型喉癌的效果更好。 展开更多
关键词 早期声门型喉癌 低温等离子射频消融术 喉部分切除术 喉功能
下载PDF
经口CO_(2)激光甲状软骨窗式切除辅助微型钛板内固定对早期声门型喉癌术后喉功能的影响
13
作者 秦阳 钱茂华 王军 《海军医学杂志》 2023年第9期930-934,共5页
目的 探讨经口CO_(2)激光甲状软骨窗式切除辅助微型钛板内固定对早期声门型喉癌术后喉功能的影响。方法选取2019年2月至2021年2月南通市第一人民医院收治的81例早期声门型喉癌患者资料进行回顾性分析。根据手术方式分为激光切除组(43例... 目的 探讨经口CO_(2)激光甲状软骨窗式切除辅助微型钛板内固定对早期声门型喉癌术后喉功能的影响。方法选取2019年2月至2021年2月南通市第一人民医院收治的81例早期声门型喉癌患者资料进行回顾性分析。根据手术方式分为激光切除组(43例)和内固定组(38例)。其中激光切除组行经口CO_(2)激光甲状软骨窗式切除,内固定组行经口CO_(2)激光甲状软骨窗式切除辅助微型钛板内固定术。统计2组患者的围手术期情况、发音功能、吞咽功能、拔管率以及术后并发症的发生情况。结果 内固定组声门型喉癌患者的手术时间长于激光切除组(P<0.05),术中出血量与住院时间比较差异无统计学意义(P>0.05),内固定组患者术后20 d的拔管率高于激光切除组(P<0.05),拔管天数短于激光切除组(P<0.05),2组患者的术后并发症发生率比较差异无统计学意义(P>0.05)。内固定组声门型喉癌患者的发音功能优良率高于激光切除组(P<0.05),吞咽功能与激光切除组比较差异无统计学意义(P>0.05)。结论 经口CO_(2)激光甲状软骨窗式切除辅助微型钛板内固定有助于促进早期声门型喉癌患者术后喉功能恢复,喉腔生理形态基本保留,术后并发症发生率与单纯进行经口CO_(2)激光甲状软骨窗式切除术患者比较无差异。 展开更多
关键词 经口CO_(2)激光切除 微型钛板内固定 声门型喉癌 吞咽功能 发音功能
下载PDF
魏式鼻咽通气道联合声门上喷射供氧和通气技术在ERCP手术中的应用 被引量:1
14
作者 付紫辉 蒋明 +3 位作者 王尔华 张晓坤 肖江强 张以洋 《广东医学》 CAS 2023年第4期448-451,共4页
目的探讨魏式鼻咽通气道联合声门上喷射供氧和通气技术在经内镜逆行胰胆管造影术(ER-CP)中的安全性及可行性.方法把行ERCP手术患者100例随机分为声门上喷射组和鼻咽通气道给氧组,每组50例,同时分别于诱导前(T0)、诱导后(T1)、进镜入咽部... 目的探讨魏式鼻咽通气道联合声门上喷射供氧和通气技术在经内镜逆行胰胆管造影术(ER-CP)中的安全性及可行性.方法把行ERCP手术患者100例随机分为声门上喷射组和鼻咽通气道给氧组,每组50例,同时分别于诱导前(T0)、诱导后(T1)、进镜入咽部(T2)、置入十二指大乳头处(T3)和退镜(T4)时记录患者心率(HR)、平均动脉压(MAP)和脉搏血氧饱和度(SpO_(2))、并在各时间点抽取桡动脉血进行血气分析.统计每组患者发生低氧血症情况和纠正低氧血症的方法以及其他不良事件等.结果鼻咽通气道给氧组出现亚临床低氧血症(90%≤SpO_(2)<95%)8例,轻度低氧血症(75%≤SpO_(2)<90%)5例,严重低氧血症(SpO_(2)<75%或SpO_(2)<90%,持续时间>60 s)2例,其中10例是需要调节氧流量或托下颌,5例通过面罩加压给氧,1例行气管插管纠正低氧血症,而声门上喷射组没有出现低氧血症.T2、T3和T4时间点声门上喷射组PaO_(2)明显高于鼻咽通气道给氧组、声门上喷射组二氧化碳分压(PaCO_(2))在T2、T3和T4时间点显著低于鼻咽通气道给氧组.在鼻出血、口干、咽痛方面声门上喷射组高于鼻咽通气道给氧组,在胃胀气、体动致手术暂停方面鼻咽通气道给氧组高于声门上喷射组.结论魏式鼻咽通气道联合声门上喷射供氧和通气技术在ER-CP手术中能够明显降低低氧血症的发生率,是安全可靠的. 展开更多
关键词 声门上喷射供氧和通气 魏氏鼻咽通气道 经内镜逆行胰胆管造影术
下载PDF
低温等离子喉部分切除术治疗早期声门型喉癌的临床疗效分析 被引量:3
15
作者 王正 许晓燕 卫旭东 《中国眼耳鼻喉科杂志》 2023年第1期77-81,共5页
目的 探讨喉垂直部分切除术和低温等离子喉部分切除术治疗早期声门型喉癌的临床疗效。方法收集选取2016年1月~2020年1月于甘肃省人民医院耳鼻咽喉头颈外科就诊并住院的早期声门型喉癌患者55例,所有患者各项资料完备且能有效随访。术后随... 目的 探讨喉垂直部分切除术和低温等离子喉部分切除术治疗早期声门型喉癌的临床疗效。方法收集选取2016年1月~2020年1月于甘肃省人民医院耳鼻咽喉头颈外科就诊并住院的早期声门型喉癌患者55例,所有患者各项资料完备且能有效随访。术后随访6~24个月。结果 与喉垂直部分切除术相比,低温等离子射频消融术的手术时间短、术中出血量少、住院时间短;同时,术后并发症少且发生率低,对喉部功能的保留较好;复发率上无明显差别。结论 低温等离子喉部分切除术治疗早期声门型喉癌效果满意,是一种有效的微创手术方法。 展开更多
关键词 喉癌 声门型喉癌 早期 低温等离子射频消融术 喉垂直部分切除术
下载PDF
PTTG1、LncRNA H19的表达与早期声门型喉癌经口内镜CO_(2)激光切除术后远期疗效的相关性 被引量:1
16
作者 刘健丰 陈建良 +2 位作者 徐允良 吴勇 吴虹 《海军医学杂志》 2023年第2期162-167,共6页
目的探讨垂体肿瘤转化基因(pituitary tumor transforming gene,PTTG1)、长链非编码RNA(long noncoding RNA,LncRNA)H19的表达与早期声门型喉癌行经口内镜CO_(2)激光切除术后远期疗效的相关性。方法选取2016年3月至2021年3月宜兴市人民... 目的探讨垂体肿瘤转化基因(pituitary tumor transforming gene,PTTG1)、长链非编码RNA(long noncoding RNA,LncRNA)H19的表达与早期声门型喉癌行经口内镜CO_(2)激光切除术后远期疗效的相关性。方法选取2016年3月至2021年3月宜兴市人民医院收治的96例确诊为早期声门型喉癌并接受经口内镜CO_(2)激光切除术治疗的患者作为研究对象。检测入组患者的血清PTTG1及癌组织、癌旁组织中LncRNA H19表达水平,并收集患者的一般资料。对行经口内镜CO_(2)激光切除术的患者的远期疗效进行单因素分析后,应用Logistic回归分析分析风险因素与术后预期疗效的相关性。结果分析声门型喉癌患者血清PTTG1表达水平,根据淋巴结转移、肿瘤分期和分化程度对患者分组比较,差异有统计学意义(t=3.160,7.740,4.840;P<0.05)。分析组织中LncRNA H19表达,根据TNM(T是指原发肿瘤,N是区域淋巴结、M是指远处转移)、分化程度及淋巴结转移对患者分组比较,差异有统计学意义(χ^(2)=4.000,5.000,9.058;P<0.05)。喉癌显微激光手术疗效单因素分析,声门型喉癌浸润方向累及声门下区、分化程度及LncRNA H19和PTTGI表达水平比较,差异有统计学意义(χ^(2)=49.878,26.923,9.909,6.891,5.008,7.563,9.643,9.028;P<0.05)。Logistic回归分析结果显示,向下累及声门下区、高LncRNA H19、PTTG1表达水平均是影响早期声门型喉癌患者经口内镜CO_(2)激光切除术后远期疗效的独立预后因素(OR=13.649,95%CI:1.891~98.365;OR=12.466,95%CI:1.715~90.606;OR=11.045,95%CI:9.314~099;P<0.05)。结论声门型喉癌患者血清PTTG1、癌组织LncRNA H19表达水平均上调,这都与喉癌的发生发展密切相关,可作为早期声门型喉癌经口内镜CO_(2)激光切除术后疗效评估的参考指标。 展开更多
关键词 PTTG1水平 LncRNA H19水平 早期声门型喉癌 经口内镜CO_(2)激光切除术 远期疗效
下载PDF
显微支撑喉镜低温等离子射频消融治疗早期声门型喉癌的效果 被引量:1
17
作者 张燕丽 叶琳 杨亚萍 《实用癌症杂志》 2023年第10期1604-1607,共4页
目的探讨显微支撑喉镜低温等离子射频消融治疗早期声门型喉癌的效果。方法选取74例早期声门型喉癌患者,随机分为显微镜组和切除术组,各37例。切除术组采用单纯喉部分切除术治疗,显微镜组采用显微支撑喉镜低温等离子射频消融治疗。对比2... 目的探讨显微支撑喉镜低温等离子射频消融治疗早期声门型喉癌的效果。方法选取74例早期声门型喉癌患者,随机分为显微镜组和切除术组,各37例。切除术组采用单纯喉部分切除术治疗,显微镜组采用显微支撑喉镜低温等离子射频消融治疗。对比2组围术期情况、黏膜恢复评分、疼痛视觉模拟(VAS)评分、嗓音声学功能、炎性因子及并发症。结果和切除术组对比,显微镜组术中出血量较少,手术时间、住院时间均较短;术后4周黏膜恢复评分较高,术后1 d VAS评分较低;术后6个月显微镜组基频微扰、标准化噪声能力、振幅微扰均较低;术后1 d显微镜组C反应蛋白(CRP)、白介素-6(IL-6)水平均较低,白介素-2(IL-2)水平较高(P<0.05)。显微镜组并发症总发生率为2.70%(1/37),较切除术组24.32%(9/37)低(P<0.05)。结论对早期声门型喉癌患者采用显微支撑喉镜低温等离子射频消融治疗,可减少术中出血量,减轻炎性应激,加快患者术后恢复,并可改善嗓音声学功能,且安全性更高。 展开更多
关键词 早期 声门型喉癌 显微支撑喉镜低温等离子射频消融
下载PDF
CO_(2)激光声带切除术联合低温等离子对早期声门型喉癌患者嗓音声带黏连的影响
18
作者 魏兴 段礼府 +4 位作者 鄢斌成 蒋宗玲 吴红英 胡一勇 马仁强 《河北医学》 CAS 2023年第7期1174-1178,共5页
目的:探讨CO_(2)激光声带切除术联合低温等离子对早期声门型喉癌(EGC)患者嗓音、声带黏连的影响。方法:回顾性收集2019年3月至2022年6月期间本院收治的行手术治疗的72例EGC患者的临床资料,按照不同治疗方法分为观察组(n=42)和对照组(n=... 目的:探讨CO_(2)激光声带切除术联合低温等离子对早期声门型喉癌(EGC)患者嗓音、声带黏连的影响。方法:回顾性收集2019年3月至2022年6月期间本院收治的行手术治疗的72例EGC患者的临床资料,按照不同治疗方法分为观察组(n=42)和对照组(n=30)。对照组采用CO_(2)激光声带切除术治疗,观察组采用CO_(2)激光声带切除术联合低温等离子治疗。比较两组手术前后嗓音指标、近期疗效、生活质量得分及并发症发生率。结果:手术后6个月,两组基频微扰、振幅微扰较手术前均下降,最长发声时间(MPT)较手术前均延长,与对照组比较,观察组术后基频微扰、振幅微扰、MPT均显著优于对照组,差异有统计学意义(1.15±0.49%vs1.36±0.31%,t=2.068,P=0.042,2.69±0.85%vs3.32±0.54%,t=3.573,P=0.001,15.69±1.84vs13.17±1.69,t=5.924,P=0.000)。与对照组比较,观察组总有效率显著升高,差异有统计学意义(95.24vs76.67,χ^(2)=5.518,P<0.05)。手术后6个月,两组生活质量量表各项得分及总分较手术前均下降,且手术后与对照组比较,观察组生活质量量表各项得分及总分显著低于对照组,差异有统计学意义(4.31±1.28vs6.39±0.54,t=8.371,P=0.000,10.25±1.32vs11.39±1.07,t=3.901,P=0.000,7.11±0.94vs7.56±0.53,t=2.364,P=0.021,17.83±2.34vs20.62±1.71,t=5.552,P=0.000)。两组声带黏连、肉芽肿发生率和并发症总发生率比较,差异无统计学意义(P>0.05)。结论:CO_(2)激光联合低温等离子疗法治疗EGC可进一步提高临床疗效,改善嗓音质量和生活质量。 展开更多
关键词 早期声门型喉癌 CO_(2)激光声带切除术 低温等离子 声带黏连
下载PDF
窄带成像技术指导声门型喉鳞状细胞癌内镜手术切缘范围的意义
19
作者 孙贵虎 李大伟 +2 位作者 郭爽 张冬梅 崔世会 《中国现代医生》 2023年第16期55-58,共4页
目的探讨窄带成像技术(narrow-band imaging,NBI)指导声门型喉鳞状细胞癌内镜手术切缘范围的临床意义。方法选取2018年2月至2020年2月于大连市第三人民医院就诊的喉鳞状细胞癌患者66例,所有患者术前均分别应用NBI模式与白光模式评估黏... 目的探讨窄带成像技术(narrow-band imaging,NBI)指导声门型喉鳞状细胞癌内镜手术切缘范围的临床意义。方法选取2018年2月至2020年2月于大连市第三人民医院就诊的喉鳞状细胞癌患者66例,所有患者术前均分别应用NBI模式与白光模式评估黏膜病变范围及病变周围细微血管形态,并确定手术切除范围;术中分别应用两种不同模式指导切除肿瘤,比较两种模式对应的冰冻病理结果,记录肿瘤复发率及并发症。结果NBI模式的诊断符合率、敏感度、特异性、阳性预测值及切缘阴性率分别为96.9%、85.7%、97.5%、66.7%、94.5%;白光模式的诊断符合率、敏感度、特异性、阳性预测值及切缘阴性率分别为82.8%、61.5%、88.2%、57.1%、79.7%。所有患者均未出现术中或术后出血、血肿、涎腺瘘等严重并发症。1年内术后复发3例,复发率4.5%。结论NBI模式可更准确地判断声门型喉鳞状细胞癌的手术切除范围,降低因肿瘤不完全切除而导致的局部复发风险。 展开更多
关键词 声门型喉鳞状细胞癌 窄带成像技术 安全切缘
下载PDF
早期声门型喉癌患者喉裂开肿瘤切除术后放置V形喉硅胶膜的临床效果
20
作者 彭晶 张超 +2 位作者 汪佳俊 曹萌 王艳艳 《实用癌症杂志》 2023年第11期1877-1880,共4页
目的 探讨早期声门型喉癌患者喉裂开肿瘤切除术后放置V形喉硅胶膜的临床效果。方法 选取80例早期声门型喉癌患者,按随机数字表法分为2组,各40例。2组均行喉裂开切除肿瘤术治疗,对照组术后放置T形喉硅胶膜,观察组术后放置V形喉硅胶膜,术... 目的 探讨早期声门型喉癌患者喉裂开肿瘤切除术后放置V形喉硅胶膜的临床效果。方法 选取80例早期声门型喉癌患者,按随机数字表法分为2组,各40例。2组均行喉裂开切除肿瘤术治疗,对照组术后放置T形喉硅胶膜,观察组术后放置V形喉硅胶膜,术后随访6个月。比较2组疼痛程度、发音功能、吞咽功能、生活质量。结果 观察组疼痛程度低于对照组,差异有统计学意义(P<0.05)。观察组术后基屏微扰(jitter)[(1.13±0.15)%]、振幅微扰(shimmer)[(2.63±0.35)%]低于对照组[(1.25±0.18)%、(3.41±0.41)%],谐噪比(HNR)[(22.89±2.14)dB]高于对照组[(20.05±2.07)dB],有统计学差异(P<0.05)。观察组术后吞咽功能优于对照组,生活质量中生理领域评分[(84.53±6.19)分]、心理领域评分[(82.58±6.14)分]、社会领域评分[(89.31±7.25)分]及环境领域评分[(90.65±6.29)分]高于对照组[(78.84±6.05)分、(76.35±5.89)分、(82.64±7.15)分、(84.75±6.12)分],有统计学差异(P<0.05)。结论 早期声门型喉癌患者术后放置V形喉硅胶膜效果更佳,能够减轻术后疼痛,加快发音及吞咽功能恢复,改善术后生活质量。 展开更多
关键词 声门型喉癌 喉裂开切除术 V形喉硅胶膜 呼吸功能 吞咽功能
下载PDF
上一页 1 2 13 下一页 到第
使用帮助 返回顶部